Omnicell (OMCL) : The consensus on Omnicell (OMCL) based on 6 analyst recommendation on the company stock is 1.33, which is interpreted as a Strong Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 5 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 1 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.
Omnicell (OMCL) : The highest short term price target forecast on Omnicell (OMCL) is $46 and the lowest target price is $33. A total of 5 equity analysts are currently covering the company. The average price of all the analysts is $38.8 with a standard deviation of $4.97.
For the current week, the company shares have a recommendation consensus of Buy. Omnicell (NASDAQ:OMCL): The stock opened at $37.39 on Thursday but the bulls could not build on the opening and the stock topped out at $37.71 for the day. The stock traded down to $37.25 during the day, due to lack of any buying support eventually closed down at $37.32 with a loss of -0.24% for the day. The stock had closed at $37.41 on the previous day. The total traded volume was 126,682 shares.
In a related news, The director, of Omnicell, Inc, Petersmeyer Gary S had unloaded 8,750 shares at $37.84 per share in a transaction on August 3, 2016. The total value of transaction was $331,100. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company has two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is organized around the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. The Companys products include OmniRx, SinglePointe, AnywhereRN, OptiFlex MS, OptiFlex CL, AccuFlex, Autobond, AutoGen, and SureSeal, among others.